CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN C...

Por E. V. Privalova, V. Yu. Kaplunova, N. V. Khabarova, G. A. Shakaryants, Yu. N. Belenkov
Publicado em 2013-02-01

Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy

Por F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, E. V. Privalova, Yu. N. Belenkov
Publicado em 2022-03-01

Hypertrophic Cardiomyopathy and Connective Tissue Dysplasia Syndrome: Comorbidity Variants

Por Yu. N. Belenkov, E. V. Privalova, V. Yu. Kaplunova, I. S. Chekneva, Yu. I. Najmann, M. V. Kozhevnikova, G. A. Shakaryants, A. S. Lishuta
Publicado em 2016-11-01

Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria

Por Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta
Publicado em 2018-11-01

Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus

Por Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
Publicado em 2019-07-01

Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy

Por F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, D. A. Yatsenko, А. V. Emelianov, A. S. Lishuta, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
Publicado em 2021-07-01